Catalyst Wire Dossier Catalyst Wire Dossier

MCI-186

edaravone · Tanabe Pharma Corporation
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for MCI-186, covering 2014-05-12 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects [Phase 1]

See pricing